Westlake BioPartners Opportunity Fund I L.P. insider trades

Open-market stock purchases and sales by Westlake BioPartners Opportunity Fund I L.P., 10% Owner at Kyverna Therapeutics, Inc, from SEC Form 4 filings since Dec 18, 2025.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -24%.

Recent trades

DateStockTradeValue
Dec 18, 2025KYTX Kyverna Therapeutics, IncBought$1M

Companies traded

  • KYTX Kyverna Therapeutics, Inc: 1 buy, last Dec 18, 2025

Get free alerts when Westlake BioPartners Opportunity Fund I L.P. files a new trade →